开放获取期刊获得更多读者和引用
700 种期刊 和 15,000,000 名读者 每份期刊 获得 25,000 多名读者
Tan Jiao Jie Cherie, Clarice Choong Shi Hui
Follicular Lymphoma (FL) remains a highly heterogeneous entity with various outcomes. In some patients, the disease exhibits aggressive and chemotherapy-resistant behavior. On the other hand, the disease remains indolent with durable remissions after initial treatment.
Such complexity in risk-stratifying patients is more so important in elderly patients with FL where early detection of the progression of the disease can lead to early treatment and prolongation of the quality of life.
Several studies suggest that disease recurrence within 2 years of first-line treatment of FL occurs consistently in as many as 20% of patients independent of maintenance rituximab.